Holden Stuart - Insider Non-Derivative Transactions at UroGen Pharma Ltd. (URGN) - (SEC)

Updated on March 12, 2026.

According to recent SEC insider information filed on Nov 26, 2025, Holden Stuart's relationship to UroGen Pharma Ltd. (URGN) is Director, and currently has 2,000 shares of ordinary shares.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other URGN insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Holden Stuart - Insider Non-Derivative Transactions of URGN ordinary shares

Holden Stuart - Insider Non-Derivative Transactions at URGN

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Nov 27, 2025	M -- (ordinary shares)	2000	0	2000